Quest Diagnostics launches Zika antibody test

Quest Diagnostics released Wednesday a new antibody test, authorized by the Food and Drug Administration for emergency use, which can help diagnose Zika virus infections.

Advertisement

The CDC licensed the test’s use by Quest Diagnostics and other select national reference laboratories to help with the response to the Zika virus outbreak.

Antibody tests are most useful two to 12 weeks following the onset of symptoms, while molecular testing is useful up to 14 days after symptom onset.

As of Sept. 14, more than 3,175 people in the U.S. had Zika, according to the CDC.

More articles on Zika:
Scientists able to detect traces of Zika from eye swabs
Florida Zika update: Miami Beach transmission zone expands, Wynwood makes progress in mosquito control
New science proves Zika causes microcephaly

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.